Robert Marshall

Robert Marshall, MBA, is a seasoned pharmaceutical sales professional with extensive experience in the biopharmaceutical industry. Currently serving as a Rare Disease Sales Representative and Ultracare Liaison at Ultragenyx Pharmaceutical Inc. since March 2021, Robert previously held various roles at Amgen from 2003 to May 2020, including Senior Biopharmaceutical Sales Representative for the Bone and Cardiovascular Business Unit and Regional Account Manager for the Corporate Accounts in the Senior Care Segment. Robert's achievements at Amgen included the successful launch of key products like Prolia and Repatha, as well as strategic marketing in long-term care for anemia management. Prior to Amgen, Robert was a Pharmaceutical Sales Specialist at Pfizer, where impressive territory rankings and product performance were achieved. Robert holds an MBA from Mount Vernon Nazarene University and a BA in Business from Otterbein University.